Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2009
12/10/2009US20090306126 Indole Derivatives
12/10/2009US20090306125 Mitochondria-Targeted Antioxidant Prodrugs and Methods of Use
12/10/2009US20090306124 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors
12/10/2009US20090306122 Substituted tetrahydropyrroloquinoline derivatives as kinase modulators, especially of tyrosine and raf kinases
12/10/2009US20090306121 Aza-beta-carbolines and methods of using same
12/10/2009US20090306110 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
12/10/2009US20090306107 Organic Compounds
12/10/2009US20090306095 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
12/10/2009US20090306089 Compounds
12/10/2009US20090306088 Substituted heteroaryl pyridopyrimidone derivatives
12/10/2009US20090306086 Compounds and methods for kinase modulation, and indications therefor
12/10/2009US20090306085 Hcv protease inhibitors and uses thereof
12/10/2009US20090306084 Heteroaryl 11-beta hydroxysteroid dehydrogenase type i inhibitors
12/10/2009US20090306071 such as 2-cyclopentyl-9-(1-methyl-1H-pyrazol-4-yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one, used for treatment of myeloproliferative disorders or cancer
12/10/2009US20090306055 Phenylazole compounds, production process and antioxidants
12/10/2009US20090306054 Integrase inhibitors
12/10/2009US20090305998 Hsp90 inhibitors
12/10/2009US20090305892 Pyrido[2,3-b]pyrazine derivatives useful as herbicidal compounds
12/10/2009US20090301552 Chlorinated naphthalenetetracarboxylic acid derivatives, preparation thereof and use thereof in organic electronics
12/10/2009CA2726588A1 Compounds and methods for treating inflammatory and fibrotic disorders
12/10/2009CA2726449A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/10/2009CA2726358A1 Inhibitors of akt activity
12/10/2009CA2726317A1 Inhibitors of akt activity
12/10/2009CA2725616A1 [4-(1-amino-ethyl) -cyclohexyl] -methyl-amine and [6-(1-amino-ethyl) -tetrahydro- pyran-3-yl] -methyl-amine derivatives as antibacterials
12/10/2009CA2725538A1 Indane derivatives as ampa receptor modulators
12/10/2009CA2724878A1 3,4-dihydropyrimidine trpa1 antagonists
12/09/2009EP2130831A1 CDC25 inhibitors
12/09/2009EP2130822A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents
12/09/2009EP2130820A1 Antipruritics
12/09/2009EP2130541A2 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
12/09/2009EP2129673A1 Amimomethyl azaadamantane derivatives and use thereof as selective modulators of the alpha7- neuronal nicotinic acetylcholine receptor (nnrs)
12/09/2009EP2129672A1 Azaadamantane ester and carbamate derivatives and methods of use thereof
12/09/2009EP1809627B1 Synthesis of heteroaryl acetamides from reaction mixtures having reduced water content
12/09/2009EP1735309B1 An improved process for the preparation of n-([1,2,4]triazolopyrimidin-2-yl)aryl sulfonamides
12/09/2009EP1692140B1 Compositions useful as inhibitors of protein kinases
12/09/2009EP1678172B1 Azabicyclic compounds for relieving pain and treating central nervous system disorders
12/09/2009EP1554256B1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
12/09/2009EP1519939B1 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
12/09/2009CN101600717A 2- piperazin-1-yl-3h-imidazo[4,5-b]pyridine derivatives
12/09/2009CN101600716A An improved process for preparation of 9-hydroxy-3-(2-chloroethyl)- 2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one hydrochloride
12/09/2009CN101600715A Compounds having both angiotensin ii receptor antagonism and ppary activating activities
12/09/2009CN101600714A Novel kinase inhibitors
12/09/2009CN101600706A Akt活性抑制剂 Akt activity inhibitor
12/09/2009CN101597294A 3-aminoalkaneacylamino-rutaecarpine and 3-aminoalkaneacylamino-7,8-dehydrorutaecarpine derivative
12/09/2009CN101597293A Method for preparing purrocoline derivatives by microwave reaction
12/09/2009CN101597292A 2, 4, 6 substituent-pyridino-(3, 2-d) pyridine derivates and application thereof
12/09/2009CN101597291A 2-aminoacyl tryptophyl-Beta-tetrahydric carboline-3-carboxylic acid carbobenzoxy as well as preparation method and application thereof
12/09/2009CN101597290A Beta-carboline-3-formyl tryptophyl amine acid carbamate as well as preparation method and application thereof
12/09/2009CN101597289A 2-tryptophanyl-Beta-tetrahydric carboline-3-formyol amino-acid benzyl ester and preparation method and application thereof
12/09/2009CN101597288A 2-aminoacyl-Beta-3-formyol tryptophan benzyl ester and preparation method and application thereof
12/09/2009CN100567295C Synthesis method of red doped material BDCJT for OLED device
12/09/2009CN100567294C N型有机半导体材料 N-type organic semiconductor material
12/09/2009CN100567293C N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists
12/09/2009CN100567289C 2-(hetero)aryl substituted tetrahydroquinoline derivatives
12/09/2009CN100567270C Sulfonyl amide derivatives
12/08/2009US7629605 N-type semiconductor materials for thin film transistors
12/08/2009US7629468 Neuroprotectants, analgesics or anticonvulsants
12/08/2009US7629465 Reacting 2-(2-thieno)ethylamine with paraformaldehyde to form 4,5,6,7-tetrahydrothieno(3,2-c)pyridine which is then reacted with a halobenzene without isolating 2-(2-thienyl)ethyl formimine; one pot cyclization
12/08/2009US7629350 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one
12/08/2009US7629338 for treating migraine, headaches; N-[(4S)-3-Methyl-2,5-dioxo-1',3'-dihydrospiro[imidazolidine-4,2'-inden]-5'-yl]-2-((6+-)-2-oxo-6-phenylpiperidin-1-yl)acetamide
12/08/2009US7629337 Chemokine receptor binding heterocyclic compounds
12/08/2009CA2485916C Non-nucleoside reverse transcriptase inhibitors
12/08/2009CA2422354C Pyrazole compounds useful as protein kinase inhibitors
12/08/2009CA2361525C Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
12/03/2009WO2009146358A1 Imidazopyridine and related analogs as sirtuin modulators
12/03/2009WO2009146034A2 Mapk/erk kinase inhibitors and methods of use thereof
12/03/2009WO2009145323A1 Method for oxidizing alcohol by using polycyclic compound
12/03/2009WO2009144734A1 Process for preparation of tadalafil
12/03/2009WO2009144494A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states
12/03/2009WO2009144395A1 Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2- α] pyridines, and preparation and therapeutic use thereof
12/03/2009WO2009144394A1 Polysubstituted 2-aryl-6-phenyl-imidazo[l,2- α] pyridine derivatives, and preparation and therapeutic use thereof
12/03/2009WO2009144392A1 Polysubstituted derivatives of 6-heteroaryl-imidazo[l,2- α] pyridines, and preparation and therapeutic use thereof
12/03/2009WO2009144391A1 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[l,2- α] pyridines, and preparation and therapeutic use thereof
12/03/2009WO2009144302A1 Semiconductor materials and methods of preparation and use thereof
12/03/2009WO2009144288A1 Process to prepare paliperidone and intermediates thereof
12/03/2009WO2009144205A1 Rylene-based semiconductor materials and methods of preparation and use thereof
12/03/2009WO2009144201A1 Imidazopyridine derivatives as gpr4 receptor modulators
12/03/2009WO2009144159A1 Substituted pyridin-4-yl-methyl sulfonamidesas fungicides
12/03/2009WO2009125425A3 Improved process for the preparation of (s.s)-2.8-diazabicyclo[4.3.0]nonane
12/03/2009WO2009122034A3 Novel dhsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
12/03/2009WO2009120717A3 Pyrido [3, 4-b] indoles and methods of use
12/03/2009WO2009118655A3 Highly pure paliperidone or a pharmaceutically acceptable salt thereof substantially free of keto impurity
12/03/2009WO2009118296A3 Novel substituted imidazoquinolines
12/03/2009WO2009115572A3 Novel heterocyclic compounds and uses therof
12/03/2009WO2009101185A3 A polymorphic form of a pyrazino [2, 3-h] [3] benzazepine derivative
12/03/2009WO2009091856A3 Beta-lactamase inhibitors
12/03/2009WO2009089076A3 Processes for the preparation and purification of paliperidone palmitate
12/03/2009US20090299070 Organic Semiconductors and Their Manufacture
12/03/2009US20090298867 Tricyclic delta-opioid modulators
12/03/2009US20090298866 Indole Compounds
12/03/2009US20090298865 Derivatives of pyrrolopyridine-2-carboxamides, preparation thereof and therapeutic application thereof
12/03/2009US20090298846 such as 6-[2-(4-Hydroxyphenyl)ethylamino]-11H-indolo[3,2-c]quinoline, used to inhibit both growth of cancer cells and activity of telomerase
12/03/2009US20090298837 poly(ADP-ribose) polymerase (PARP) inhibitors such as 9-[(Hydrozinooxy)carbonyl]-2,7-dihydro-6-methoxy 3H-pyrido-[4,3,2-de]phthalazin-3-one, used for treating neuron tissue damage resulting from ischemia and reperfusion injury, depression, inflammatory bowel disorders, arthritis, gout, pain and sepsis
12/03/2009US20090298821 Hydroxy and alkoxy substituted ih-imidazonaphthyridines and methods
12/03/2009US20090298820 3-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
12/03/2009US20090298811 Benzimidazolone derivatives
12/03/2009US20090298810 IL-8 Receptor Antagonists
12/03/2009US20090295274 Deuterated Semiconducting Organic Compounds for Use in Light-Emitting Devices
12/03/2009DE102008025751A1 New 4-(1H-pyrrolo(2,3-b)pyridin-3-yl)-pyridin-2-yl-amine derivatives are serine kinase modulators, useful to treat solid tumors, tumor growth, tumor metastasis, AIDS, occlusive neointimal lesions, arteriosclerosis, coronary artery disease
12/03/2009CA2726262A1 Imidazopyridine and related analogs as sirtuin modulators
1 ... 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 ... 646